Health Journal Online

Tag: Angeles

  • HEALTH ALERT: Los Angeles Drinking Water Tested Positive for Lead and Cancer-Linked Chemicals — City Council Demands Emergency Investigation

    HEALTH ALERT: Los Angeles Drinking Water Tested Positive for Lead and Cancer-Linked Chemicals — City Council Demands Emergency Investigation

    LOS ANGELES — In a unanimous 10-0 vote that sent shockwaves through City Hall, the Los Angeles City Council has demanded an immediate investigation by the Department of Water and Power (LADWP) and the city’s Housing Authority after samples of drinking water in the Watts neighborhood were found to contain elevated levels of lead. The discovery has drawn national comparisons to Flint, Michigan — where a decade-long water contamination crisis poisoned a generation of children — and has raised urgent questions about the safety of tap water across one of America’s largest and most densely populated cities.

    An analysis of LADWP’s own 2026 water quality data, reviewed by the Environmental Working Group (EWG), reveals a troubling picture: several contaminants are present at levels that exceed the EWG’s health guidelines, even if they remain within the EPA’s more permissive regulatory limits. The distinction matters enormously for public health — particularly for children, pregnant women, and communities with the least access to filtered or bottled water alternatives.

    Lead in Watts: The Crisis That Triggered a City Council Vote

    The Watts neighborhood — one of Los Angeles’s most historically marginalized communities, with a majority-Black and Latino population — has experienced chronic environmental health challenges for decades. The discovery of lead in tap water samples collected from Watts public housing units was not entirely surprising to residents who have complained about water quality for years. What was surprising was the speed and unanimity of the City Council’s response: a 10-0 vote demanding emergency action.

    Lead is a potent neurotoxin. There is no safe level of lead exposure for children, according to the CDC, which lowered its reference blood lead level threshold to 3.5 micrograms per deciliter (mcg/dL) in 2021 — acknowledging that even previously “acceptable” levels cause measurable cognitive and developmental harm. For children under 6, whose brains are still developing, lead exposure causes irreversible reductions in IQ, increased impulsivity and aggression, and long-term learning disabilities.

    The primary suspected source of the lead in Watts’s water is aging infrastructure: lead service lines and lead solder in the plumbing of older buildings. Many housing units in Watts were constructed before 1978, the year lead-based paint was banned nationally, and before the widespread replacement of lead plumbing. When water sits in lead pipes overnight, it leaches the metal, delivering it straight to the morning’s first glass or the baby’s formula.

    Beyond Lead: Chromium-6 and PFAS in LA’s Water Supply

    Lead is not the only contaminant of concern in Los Angeles’s water. The LADWP’s 2026 water quality data shows that Chromium-6 — the carcinogenic industrial chemical made internationally infamous by the Erin Brockovich case — has been detected in LADWP water at levels below California’s proposed regulatory standard of 10 parts per billion (ppb), but significantly above the EWG’s health guideline of 0.02 ppb, which is based on National Toxicology Program studies linking chromium-6 to gastrointestinal tumors.

    The sources of chromium-6 in LA’s water include natural chromium in the geology of Eastern Sierra source water areas, historical industrial use of chromium compounds in the San Fernando Valley, and regional industrial contamination that has leached into groundwater. Standard activated carbon filters — like Brita pitchers used by millions of Americans — do not remove chromium-6. Only reverse osmosis or anion exchange resin filtration systems are effective.

    PFAS (per- and polyfluoroalkyl substances, commonly called “forever chemicals”) contamination is also a growing concern in the greater LA region, particularly in groundwater sources in the San Gabriel and San Fernando Valleys. PFAS are associated with kidney cancer, thyroid disease, immune suppression, and developmental harm in children. For more information on PFAS in drinking water, visit the EPA PFAS resource page.

    Who Is Most at Risk — and What They Can Do

    The residents most at risk from LA’s water quality issues are those who lack the economic resources to purchase bottled water, install filtration systems, or move to neighborhoods with newer plumbing. That demographic overwhelmingly overlaps with the populations already bearing the greatest burden of environmental harm in Los Angeles: low-income communities of color in South LA, East LA, and the San Fernando Valley.

    For residents concerned about lead exposure specifically, the following precautions are recommended by the Los Angeles County Department of Public Health and the EPA:

    • Use only cold tap water for drinking, cooking, and making baby formula. Hot water leaches more lead from pipes.

    • Flush your tap for at least 30 seconds to 2 minutes before using it for the first time each morning, or after extended periods of non-use.

    • Consider installing an NSF-certified water filter rated specifically for lead removal. Pitcher-style filters (Brita, Pur) do NOT reliably remove lead. Look for filters certified under NSF Standard 53.

    • Have children under 6 and pregnant women tested for blood lead levels. Talk to your pediatrician or call the LA County Department of Public Health.

    Residents can also request a free lead-in-water test kit from the LA County Department of Public Health. More information is available at publichealth.lacounty.gov.

    Conclusion: The Watts Crisis Is a Preview of a Citywide Reckoning

    The Watts water contamination episode is not an isolated plumbing problem. It is a symptom of a systemic failure to prioritize infrastructure investment in communities that have long been told their concerns would be addressed “eventually.” Flint, Michigan waited years for “eventually.” The lesson from Flint — that regulatory compliance thresholds protect utilities, not people — must not be repeated in Los Angeles. The EWG’s data makes clear that LA’s water contains chemicals that exceed science-based health guidelines even when they technically comply with EPA rules.

    A city as wealthy and as large as Los Angeles has both the resources and the obligation to close the gap between what the law permits and what public health demands. The unanimous City Council vote is a first step. The work of actually replacing aging lead lines, upgrading filtration, and ensuring equitable access to clean water for all 4 million residents of the city is the much harder task that lies ahead.

    RELATED ON MEDICALDAILY.COM

    • Flint Happened There. Now It’s Los Angeles: The Ongoing Lead and Toxic Chemical Crisis in LA’s Drinking Water

    • What Are PFAS “Forever Chemicals” and Why Are They in Your Drinking Water?

    • Lead Exposure in Children: The Invisible Epidemic Still Harming American Kids

    • Chromium-6 in Drinking Water: A National Problem with Local Consequences

    Source link

  • Los Angeles Declared a Historic Win Against Fentanyl. Eight People Are Still Dying Every Day. Here Is What the Data Is Really Saying.

    Los Angeles Declared a Historic Win Against Fentanyl. Eight People Are Still Dying Every Day. Here Is What the Data Is Really Saying.

    When Los Angeles County officials announced in mid-2025 that overdose deaths had dropped 22 percent in 2024 — the most significant single-year decline in the county’s recorded history — the announcement was framed as a public health success story. District Attorney Nathan Hochman called it a vindication of prevention, education, and aggressive prosecution. The Los Angeles County Department of Public Health credited expanded naloxone access, harm reduction investments, and improved treatment availability.

    And on the narrow metrics cited in the press release, the numbers are genuinely encouraging. Deaths fell from 3,137 in 2023 to 2,438 in 2024. Fentanyl-related deaths specifically declined by 37 percent. Methamphetamine-related deaths dropped by 20 percent. These are not trivial improvements. In a crisis of this scale, every life saved represents a family intact, a child who still has a parent, a community that did not have to hold another funeral.

    But 2,438 people still died in Los Angeles County in a single year from drug overdoses and poisonings. That is an average of more than eight people every day. Every single day. Fentanyl — a synthetic opioid 50 times more potent than heroin and 100 times more potent than morphine — still accounted for 52 percent of all accidental overdose deaths in the county, even after the record decline. And the long-term trajectory of this crisis remains one of the most dramatic public health collapses in any American city’s modern history.

    The full LA County Department of Public Health data report on fentanyl overdoses: Data Report — Fentanyl Overdoses in Los Angeles County, October 2025. The official county announcement: Public Health Reports Most Significant Decline in Drug-Related Overdose Deaths in LA County History.

    ⚠ LOCAL DATA ALERT: In LA County, fentanyl overdose deaths surged 1,652% between 2016 and 2024. In the poorest communities (30%+ poverty rate), the fentanyl death rate is nearly FOUR TIMES higher than in the wealthiest neighborhoods — 39.1 vs. 10.0 per 100,000 population.

    THE LONG ARC: FROM 109 DEATHS TO 2,438 IN UNDER A DECADE

    To understand what Los Angeles County is actually facing, the short-term improvement must be placed in its proper context. In 2016, when routine toxicology testing for fentanyl began in LA County death investigations, 109 people died from fentanyl-related overdoses. By 2021, that number had risen to 1,504 — a 1,280 percent increase in five years. By 2023, the total had climbed to 3,137 — a 1,652 percent increase from the 2016 baseline. The 2024 decline brings the county back to roughly the 2022 level, which was itself an unprecedented crisis point.

    Fentanyl’s rise in Los Angeles has tracked a national pattern of drug supply contamination driven by illicit manufacturing. Unlike the opioid crisis of the 2000s and 2010s — which was substantially driven by overprescription of pharmaceutical opioids — the current crisis is primarily a fentanyl poisoning crisis. People who believe they are purchasing counterfeit prescription pills, cocaine, or methamphetamine are receiving products laced with illicitly manufactured fentanyl. Seven out of every 10 illicit pills seized in Los Angeles County contain a lethal dose of fentanyl, according to LA County District Attorney Nathan Hochman — who has characterized fentanyl as ‘an indiscriminate assassin.’

    The DA’s office announced several first-of-their-kind murder prosecutions for fentanyl distribution in 2025: LA County Sees Sharpest Decline in Overdose Deaths as DA Hochman Intensifies Fentanyl Fight.

    THE INEQUALITY BURIED IN THE DATA: GEOGRAPHY AND POVERTY AS DEATH SENTENCES

    The LA County October 2025 data report contains a figure that deserves to be front-page news in its own right. The rate of fentanyl overdose deaths in the least affluent communities — defined as areas where more than 30 percent of families live below the federal poverty level — was 39.1 deaths per 100,000 population in 2024. In the most affluent areas — where less than 10 percent of families are below the poverty line — the rate was 10.0 per 100,000. That is a nearly four-fold difference in death rates based solely on neighborhood income level.

    This disparity is not a natural phenomenon. It reflects differences in access to treatment and recovery services, differences in housing stability that affect treatment continuity, differences in access to naloxone and harm reduction infrastructure, differences in health insurance coverage, and differences in the concentration of street drug markets in lower-income communities. It also reflects the cumulative effect of decades of underinvestment in mental health and addiction treatment infrastructure in communities that needed it most.

    In practical terms, the geography of fentanyl death in Los Angeles correlates with neighborhoods on the south and east sides of the city and county — communities with higher concentrations of unhoused individuals, higher poverty rates, and lower access to primary care. These communities saw the highest absolute death rates at the peak of the crisis and will be the slowest to benefit from the percentage declines being celebrated at the county level.

    THE NATIONAL PICTURE: LA’S DECLINE IN CONTEXT

    Los Angeles County’s 22 percent improvement in 2024 is broadly consistent with a national trend. According to provisional data released by the CDC on May 13, 2026, approximately 69,973 people died from drug overdoses in the 12 months ending December 2025 — a 13.9 percent decline from the previous year. This represents the longest sustained decline in overdose deaths in decades: more than two full years of falling national mortality after the 2022 peak of 107,941 deaths.

    Full CDC overdose prevention data, updated May 13, 2026: CDC Overdose Prevention — About Overdose Prevention. National Institute on Drug Abuse death rate data: NIDA Overdose Death Rates.

    But as Brown University researcher Brandon Marshall noted in January 2026 reporting by U.S. News: ‘The monthly death toll is still not back to what it was before the COVID-19 pandemic, let alone where it was before the current overdose epidemic struck decades ago.’ The celebration of declining overdose numbers requires constant calibration against the baseline. Fewer people are dying than at the peak, but far more people are dying than in any year before this crisis began — and the crisis is showing no signs of resolving, only of moderating.

    THE FENTANYL VACCINE: A FUTURE SOLUTION THAT IS NOT HERE YET

    One of the most closely watched developments in overdose prevention science entering 2026 is the progression of an experimental fentanyl vaccine into early-phase human trials. The vaccine is not designed to treat opioid addiction directly but to prevent fentanyl from crossing the blood-brain barrier in individuals who use the drug — effectively reducing overdose risk by preventing the euphoric effect that drives compulsive use and by limiting the respiratory depression that causes overdose death.

    If successful, this approach could function as a pharmacological safety net for individuals in active recovery who face high relapse risk — a population for whom current naloxone-centered harm reduction strategies are important but insufficient. However, every addiction medicine specialist commenting on early trial data has been clear: widespread clinical availability of a fentanyl vaccine is likely years away, not months. It cannot be counted as a near-term solution to a crisis killing eight people per day in Los Angeles County alone.

    Background on the fentanyl crisis trajectory entering 2026: The Fentanyl Crisis in the United States Heads Into 2026 With Cautious Optimism.

    WHAT EVERY LOS ANGELES RESIDENT NEEDS TO KNOW

    Naloxone (brand name Narcan) is available without a prescription at pharmacies across Los Angeles County, and at no cost through Los Angeles County Department of Public Health distribution programs. It is the only pharmacological intervention capable of reversing a fentanyl overdose in progress. Every household in Los Angeles — not only those with someone who uses drugs — should have naloxone available. Fentanyl-laced counterfeit pills are indistinguishable from pharmaceutical tablets by appearance. A teenager who accepts what appears to be an Adderall or Xanax from a peer at a party is at risk. A young adult who takes a single pill at a social event is at risk. This is not a drug user’s problem. It is a community-wide threat.

    Fentanyl test strips — small, inexpensive paper strips that can detect fentanyl in a drug sample before consumption — are now legal in California and available through harm reduction organizations across Los Angeles. Their use does not enable drug use; it prevents death. Stigma around carrying test strips has cost lives. This is not a debate about whether drug use is acceptable. It is a debate about whether the appropriate response to a poisoned drug supply is to let people die from accidental contamination.

    Naloxone access and overdose prevention resources for Los Angeles residents: LA County Department of Public Health — Naloxone Access. National overdose prevention resource: CDC Overdose Prevention Resources.

    MEDICALDAILY.COM ASSESSMENT

    Los Angeles County’s 22 percent overdose death reduction in 2024 is real and meaningful — and it is also vastly insufficient relative to the scope of the crisis. Going from 3,137 deaths to 2,438 deaths is a step in the right direction. It is not a resolution. The nearly four-fold disparity in death rates between LA’s poorest and wealthiest communities tells a story that the headline percentage decline obscures: the communities that were hardest hit in this crisis are recovering the slowest, and the gap between them and more affluent neighborhoods may be widening rather than closing. The 1,652 percent long-term surge in fentanyl deaths since 2016 represents a civilizational failure in drug policy, mental health infrastructure, and social support systems that a single year of positive trend data cannot undo. Los Angeles has earned a moment to acknowledge the improvement. It has not earned a moment to declare victory.

    Source link

  • New Psychiatry Residency Program Launched in Los Angeles by Residents Medical and Brain Health USA

    New Psychiatry Residency Program Launched in Los Angeles by Residents Medical and Brain Health USA

    Every year on July 1, thousands of newly minted doctors across the United States begin their medical residencies, which is a critical next step in their training that allows them to put their academic knowledge to practical use. For many, this transition follows years of intense preparation, such as undergraduate education, medical school, board examinations, and a challenging application process. According to the National Resident Matching Program (NRMP), the 2024 Match saw more than 50,000 applicants vying for approximately 41,000 positions, which shows the competitive nature of medical residency placements in the United States.

    Residency candidates are assessed on a range of criteria, including their United States Medical Licensing Examination (USMLE) Step scores, letters of recommendation, and personal statements. International medical graduates (IMGs) face additional challenges, such as navigating ECFMG certification and competing for a limited pool of positions designated for non-US graduates. Despite these hurdles, IMGs make up a crucial segment of the American healthcare system, comprising more than 25 percent of the physician workforce, according to the American Medical Association.

    To meet the needs of these applicants, several organizations have stepped in to help thousands of medical school students and graduates prepare for and achieve their dream residency or fellowship. Residents Medical, headquartered in Los Angeles, California, plays a unique role in this space by helping medical students and graduates on their path to becoming residents and fellows in the United States. Through a combination of personalized mentorship, application enhancement strategies, and interview preparation techniques, the organization has worked to expand access to residency and fellowship programs, particularly in areas experiencing workforce shortages.

    Residency training itself can vary widely depending on specialty, institution, and geographic location. Psychiatry, for instance, has emerged as one of the fields most in need of new practitioners. The Health Resources and Services Administration projects a shortage of up to 31,000 psychiatrists by 2030, fueled by increased mental health awareness and provider retirement. New residency programs are being developed in response to these needs, often through collaborations between clinical facilities and academic partners.

    This July, a new ACGME-accredited psychiatry residency program officially opens its doors at Brain Health USA in Los Angeles, California. Developed with support from Residents Medical Consultancy, Brain Health USA’s Psychiatry program will help prepare physicians to meet the growing demand for mental healthcare while also reinforcing quality and compliance through accredited standards. The start of Brain Health’s new psychiatry program marks a moment in the field of graduate medical education, where mental health services have increasingly become a priority across policy and practice.

    “The country has never needed more mental health professionals than it does right now,” said Dr. Michael Everest, Founder, Chairman, & Chief Academic Officer of Residents Medical and Founder and Chairman Emeritus of the Everest Family Foundation. “Supporting a psychiatry residency at Brain Health USA allows us to help both patients and physicians at a time when access to behavioral healthcare is an urgent concern.”

    “This residency represents what we strive for, which is creating educational pathways that serve underserved communities while fostering excellence in medical training,” added Dr. Everest. “Every new GME program is an opportunity to support the next generation of healthcare professionals with tools that meet today’s challenges.”

    As the July 1 start date marks a transition for new medical residents across the country, the start of this new psychiatry residency in Los Angeles serves as a milestone and a signal. It reflects the realities of healthcare today, where mental health, educational support, and systemic access must all be addressed in tandem. Through targeted development and a commitment to quality, organizations like Residents Medical are helping reshape the journey into residency.

    Source link